Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions

Cannabis UseImpaired DrivingCognitive Impairment

Interventions

DRUG

Cannabis

cannabis with 0, 5, or 30 mg THC will be inhaled via vaporization

Trial Locations (1)

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER